What is Living Cell Technologies Limited (LVCLY)?

Living Cell Technologies Limited (LVCLY) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of LVCLY?

The current price of LVCLY is $0.03. Prices are updated in real time on Stocks360.

What is LVCLY's price-to-earnings (PE) ratio?

LVCLY's trailing twelve-month PE ratio is -3.34, based on current price and earnings per share data available on Stocks360.

What is LVCLY's market capitalization?

LVCLY's market capitalization is $11,392,472.00, placing it in the small-cap tier.

Living Cell Technologies Limited (LVCLY)

Stock analysis · OTC · Healthcare · Biotechnology

$0.03

Market Cap

$11.39M

PE (TTM)

-3.34

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.76

Day Range

$0.03 – $0.03

52-wk Range

$0.02 – $0.08

Avg Volume

N/A

Volume

244.00

Living Cell Technologies Limited (LVCLY) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $11.39M. Trailing PE -3.34. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Living Cell Technologies Limited

Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand. A primary focus for LCT is NTCELL, a novel alginate-coated capsule currently progressing through Phase IIb clinical trials for its application in treating Parkinson's disease. The company was founded in 1987 and operates from its base in Sydney, Australia.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-3.34×
P/S (TTM)	0.00×
P/B	2.40×
P/FCF (TTM)	-10.62×
EV / EBITDA	-5.94×
EV / Sales	0.00×
Earnings Yield	-28.99%
Free Cash Flow Yield	-9.41%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$13.08M
Net Income (TTM)	-$4.69M
Free Cash Flow (TTM)	-$1.52M
Net Debt	-$3.11M
Working Capital	$3.01M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-61.85%
Return on Invested Capital	-73.01%